Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Hofmann

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 2, 2021
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort studyTroels Yndigegn, Patrik Gilje, Josef Dankiewicz, et al.
American Heart Journal|March 10, 2021
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMIJoakim Alfredsson, Stefan K James, David Erlinge, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 1, 2024
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMIKatarina Mars, Sophia Humphries, Philip Leissner, et al.
International Journal of Molecular Sciences|September 28, 2023
<i>Helicobacter pylori</i> and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery DiseaseJonatan Wärme, Martin O Sundqvist, Marcus Hjort, et al.
ESC Heart Failure|March 8, 2024
Effects of pharmacological interventions on mortality in patients with Takotsubo syndrome: a report from the SWEDEHEART registryPetur Petursson, Eduard Oštarijaš, Björn Redfors, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 13, 2022
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)Troels Yndigegn, Bertil Lindahl, Joakim Alfredsson, et al.
European Heart Journal|November 27, 2024
Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registryElmir Omerovic, Truls Råmunddal, Petur Petursson, et al.
European Heart Journal|May 23, 2021
Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Sebastian Völz, Björn Redfors, Oskar Angerås, et al.
JAMA Network Open|October 1, 2020
Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With OutcomesChristian Dworeck, Björn Redfors, Oskar Angerås, et al.
The New England Journal of Medicine|April 8, 2024
Beta-Blockers after Myocardial Infarction and Preserved Ejection FractionTroels Yndigegn, Bertil Lindahl, Katarina Mars, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 2, 2021
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort studyTroels Yndigegn, Patrik Gilje, Josef Dankiewicz, et al.
American Heart Journal|March 10, 2021
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMIJoakim Alfredsson, Stefan K James, David Erlinge, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 1, 2024
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMIKatarina Mars, Sophia Humphries, Philip Leissner, et al.
International Journal of Molecular Sciences|September 28, 2023
<i>Helicobacter pylori</i> and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery DiseaseJonatan Wärme, Martin O Sundqvist, Marcus Hjort, et al.
ESC Heart Failure|March 8, 2024
Effects of pharmacological interventions on mortality in patients with Takotsubo syndrome: a report from the SWEDEHEART registryPetur Petursson, Eduard Oštarijaš, Björn Redfors, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 13, 2022
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)Troels Yndigegn, Bertil Lindahl, Joakim Alfredsson, et al.
European Heart Journal|November 27, 2024
Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registryElmir Omerovic, Truls Råmunddal, Petur Petursson, et al.
European Heart Journal|May 23, 2021
Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Sebastian Völz, Björn Redfors, Oskar Angerås, et al.
JAMA Network Open|October 1, 2020
Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With OutcomesChristian Dworeck, Björn Redfors, Oskar Angerås, et al.
The New England Journal of Medicine|April 8, 2024
Beta-Blockers after Myocardial Infarction and Preserved Ejection FractionTroels Yndigegn, Bertil Lindahl, Katarina Mars, et al.
Pageof 8